A Cross-Comparison of High-Throughput Platforms for Circulating MicroRNA Quantification, Agreement in Risk Classification, and Biomarker Discovery in Non-Small Cell Lung Cancer.

Front Oncol · 2022 · PMC9343840 · PMID 35928879

Europe PMC DOI

hedged sentence

0.0080

closest p · 0.2× alpha

0.0080

boldest claim

The sentences

a trend toward significancep -value = 0.008actually significant

A trend toward significance (nominal p -value = 0.008) was also observed in the fifth platform (OAA) ( Figure 5A ).

also in 3,729 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.